Performance of the 2019 ACR/EULAR classification criteria for IgG4-related disease and clinical phenotypes in a Spanish multicentre registry (REERIGG4)

• Published in: Rheumatology (Oxford, England) Vol. 60; no. 1; pp. 217 - 223
• Main Authors: Fernández-Codina, Andreu, Pinilla, Blanca, Pinal-Fernández, Iago, Carballo, Iago, Feijoo-Massó, Carlos, Toledano-Macías, María, de Miguel-Campo, Borja, Fonseca-Aizpuru, Eva, Sáez-Comet, Luis, López-Dupla, Miguel, Hernández-Rodríguez, José, Martínez-Valle, Fernando
• Format: Journal Article
• Language: English
• Published: England Oxford University Press 05-01-2021
• Subjects: Age Factors; Clinical Science; Cross-Sectional Studies; Databases, Factual; European Continental Ancestry Group - statistics & numerical data; Female; Humans; Immunoglobulin G - blood; Immunoglobulin G4-Related Disease - classification; Immunoglobulin G4-Related Disease - diagnosis; Immunoglobulin G4-Related Disease - ethnology; Immunoglobulin G4-Related Disease - pathology; Male; Middle Aged; Phenotype; Registries; Sex Factors; Spain; Spain; IgG4-related disease; phenotypes; classification criteria
• ISSN: 1462-0324; 1462-0332
• DOI: 10.1093/rheumatology/keaa247

Objectives
Several IgG4-related disease (IgG4-RD) phenotypes have been proposed and the first set of classification criteria have been recently created. Our objectives were to assess the phenotype distribution and the performance of the classification criteria in Spanish patients as genetic and geographical differences may exist.
Methods
We performed a cross-sectional multicentre study (Registro Español de Enfermedad Relacionada con la IgG4, REERIGG4) with nine participating centres from Spain. Patients were recruited from November 2013 to December 2018. The 2019 American College of Rheumatology/European League Against Rheumatism classification criteria (AECC) were used.
Results
We included 105 patients; 88% had Caucasian ethnicity. On diagnosis, 86% met the international pathology consensus while 92% met the Japanese comprehensive criteria. The phenotype distribution was head and neck 25%, Mikulicz and systemic (MS) 20%, pancreato-hepato-biliary (PHB) 13%, retroperitoneal and aorta (RA) 26%. Sixteen per cent had an undefined phenotype. Seventy-seven per cent of the cases met the AECC. From the 24 patients not meeting the AECC, 33% met exclusion criteria, and 67% did not get a score ≥20 points. Incomplete pathology reports were associated to failure to meet the AECC.
Conclusions
The PHB phenotype was rare among Spanish IgG4-RD patients. The MS phenotype was less frequent and the RA phenotype was more prevalent than in other, Asian patient series. An undefined phenotype should be considered as some patients do not fall into any of the categories. Three quarters of the cases met the 2019 AECC. Incomplete pathology reports were the leading causes of failure to meet the criteria.